Compare BNGO & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNGO | ADIL |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 10.2M |
| IPO Year | 2018 | 2017 |
| Metric | BNGO | ADIL |
|---|---|---|
| Price | $1.15 | $3.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.00 | ★ $8.33 |
| AVG Volume (30 Days) | ★ 271.9K | 31.7K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,000,735.00 | N/A |
| Revenue This Year | $12.73 | N/A |
| Revenue Next Year | $34.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.26 | N/A |
| 52 Week Low | $1.00 | $0.13 |
| 52 Week High | $2.23 | $9.53 |
| Indicator | BNGO | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 32.20 | 44.36 |
| Support Level | $1.10 | $2.38 |
| Resistance Level | $1.19 | $4.94 |
| Average True Range (ATR) | 0.08 | 0.35 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 13.75 | 51.42 |
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.